Image credits: Clay Banks en Unsplash
/
Weekly Roundups

Oncology, Mental Health to Receive Further Attention

By Miriam Bello | Wed, 06/22/2022 - 16:25

As global epidemiological trends shift, providers are paying increasing attention to oncology, mental health and other non-communicable diseases to generate the tools necessary to address future crises.

Here is the week in health! 

Mayo Clinic, Médica Sur Sign Agreement to Improve Cancer Care

Mayo Clinic and Médica Sur strengthened their years-long collaboration with a new agreement to improve oncology attention in Mexico. The expanded collaboration will initially focus on improving breast cancer care, including diagnosis and treatment, and will later expand to include treatment for other cancers and medical specialties.

Elimination of Psychiatric Hospitals Draws Mixed Reception

After the recent reforms to the General Health Law regarding mental health, which impact family and community care in cases where hospitalization is the last option, different organizations have vocalized their opinions on whether these changes could affect or benefit patients. Read the two views in the full article.

Drought to Continue Throughout 2022: CONAGUA

The Mexican north and northwest are facing a severe drought that might not abate until late 2022, warns the National Water Commission (CONAGUA). The commission’s Drought Monitor reports that 72.58 percent of Mexican territory is showing signs of drought, which ranges from mild to severe. This percentage is slightly lower than 15 days ago, when CONAGUA indicated that 77.68 percent of the country was suffering droughts.

About 30 million Mexicans Suffer from High Blood Pressure

The Ministry of Health estimates that one out of every four Mexicans suffers from high blood pressure, also known as hypertension, but about 46 percent of them are unaware of it. According to the National Institute of Statistics and Geography (INEGI), 30 million Mexicans suffer from this disease, representing about 24.9 percent and 26.1 percent of the male and female population, respectively. 

Inauguration Of Community Mental Health and Addictions Center

A new institute focused on early mental health care in Tapachula, Chiapas, is the first unit to transform from a Primary Addiction Care Centers (CAPA) to a Community Mental Health and Addiction Center (CECOSAMA). This makes Tapachula the first city to be part of the new model, which will reconvert 340 health centers to provide mental health and addictions assistance. By June 14, 2,987 people requested health services from this unit.

AstraZeneca, Ionis Aim for New Drug for Rare Disease

An interim analysis of eplontersen, an experimental drug developed jointly by AstraZeneca and Ionis Pharmaceuticals, showed it met the main goals of a late-stage trial in patients with amyloid transthyretin cardiomyopathy (ATTR-CM) and amyloid transthyretin polyneuropathy (ATTR-PN). The companies plan to file for a new drug application in the US to sell and market this medication.

Pfizer to Buy 8.1 Percent Stake in Vaccines Company Valneva

US healthcare giant Pfizer agreed to invest US$95 million to buy an 8.1 percent stake in French vaccines company Valneva. The drugmakers also announced an update to their collaboration and license agreement for the Lyme disease vaccine (VLA15).

Check Out More Top Stories Here:

Gender Inequalities Impact Access to Treatment

Getting Healthcare Through the Metaverse Is Now Possible

Climate Change Puts Children’s Health at Risk

Jobs in Health, Education Critical to Fight Economic Crisis: WEF

Ministry of Health Confirms More Cases of Monkeypox in Mexico

Psilocybin Could Treat Mental Disorders

Miriam Bello Miriam Bello Senior Journalist and Industry Analyst